Anti-Pot Org Claims DEA Administrator Was Not Included in Rescheduling Decision
As the federal government moves to reclassify cannabis and put it in a slightly less restrictive category, the plot thickens. On Monday, […]
Category: Paul Armentano
Cannabis Community, Investors React to DEA Decision To Reschedule
Cannabis advocates, executives and investors are celebrating the Drug Enforcement Administration’s reported decision this week to reclassify marijuana under federal drug laws, […]
Study: Canadian MJ Legalization Has No Association with Increasing Psychosis Rates
Amidst the growing cannabis reform across the West, there have been growing conversations surrounding cannabis-induced psychosis, suggesting that regular cannabis use and […]
30,000 Papers on Cannabis Published By Scientists in Last Decade
The wave of legalization that has swept over the United States in the last decade has coincided with a swell in published […]
Study: Young MJ Consumers With Psychosis Risk Saw Symptom Improvement
A new study, titled “Recreational Cannabis Use Over Time in Individuals at Clinical High Risk for Psychosis: Lack of Associations with Symptom, […]
Study: Smoking Pot Not Linked With COPD
Smoking marijuana is not associated with chronic obstructive pulmonary disease, or COPD, according to a newly released study. Researchers from the University […]
Cannabis Researchers Published 4,300 Scientific Papers in 2022
NORML recently announced that according to a PubMed.gov keyword search, there were more than 4,300 scientific research papers published about cannabis in […]